NCT05324865

Brief Summary

Schizophrenia is a mental illness that progresses with delusions or hallucinations, causes changes in interpersonal communication, thoughts and behaviors, continues with recovery and repetitions, and in which the interpretation of reality is impaired. Drug treatment alone is not sufficient in schizophrenia, and it is known that negative symptoms continue even in patients with a good response to drug treatment. For this reason, complementary therapies, psychosocial approaches and rehabilitation in addition to drug therapy increase the effectiveness of the treatment.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 12, 2022

Completed
19 days until next milestone

Study Start

First participant enrolled

May 1, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

April 12, 2022

Status Verified

April 1, 2022

Enrollment Period

2 months

First QC Date

January 10, 2022

Last Update Submit

April 11, 2022

Conditions

Keywords

Schizophrenicrelaxation exercisenursingpsychological symptoms

Outcome Measures

Primary Outcomes (3)

  • Individual Introductory Information Form

    Patients' personal information (age, gender, marital status, educational status, income status, employment status) and disease information (year of disease onset, is the drug treatment sufficient, does the drug take the drug regularly, is there a regular check-up, is there any substance addiction) (cigarette, alcohol), are there any non-drug treatment methods in the fight against the disease) constitute questions.

    10 minute

  • Warwick-Edinburgh Mental Well-Being Scale

    The scale consists of 14 positive items and has a 5-point Likert-type answer key. High scores from the scale indicate high mental well-being.

    15 minute

  • Psychiatric Rating Scale(PRS)

    This form consists of 18 items. The items of the scale are scored between 0-6. It shows that the severity of the disease increases as the scoring increases.

    15 minute

Study Arms (2)

Experimental Group

EXPERIMENTAL

Information about the experimental group was given. Progressive muscle relaxation (PMR) for 6 weeks to patients with schizophrenia will be heard. At the end of 6 weeks, psychiatric evaluation and mental well-being scale will be used.

Behavioral: Progressive Muscle Relaxation

Control Group

NO INTERVENTION

Patient identification form, psychological evaluation form and mental health form were filled in for the control group. At the end of 6 weeks, the psychological evaluation form and the mental well-being form were filled again without any intervention.

Interventions

Progressive Muscle Relaxation PMR is a technique that provides relaxation in the whole body by voluntary and regular relaxation of large muscle groups in the human body, which is included in mind-body applications.

Experimental Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Having a confirmed diagnosis of schizophrenia for at least 6 months
  • Having the ability to communicate and read,
  • Volunteering to participate in the research.

You may not qualify if:

  • Not complying with the principle of voluntarism
  • Patients in acute exacerbation period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Autogenic Training

Intervention Hierarchy (Ancestors)

HypnosisMind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nursing

Study Record Dates

First Submitted

January 10, 2022

First Posted

April 12, 2022

Study Start

May 1, 2022

Primary Completion

July 1, 2022

Study Completion

October 1, 2022

Last Updated

April 12, 2022

Record last verified: 2022-04